**Core Concept:** Disseminated Intravascular Coagulation (DIC) is a life-threatening systemic coagulation disorder characterized by increased fibrinolysis and impaired fibrin formation, leading to widespread bleeding. Gram-negative rods are a common cause of DIC, particularly in sepsis. Gram-negative organisms can invade the bloodstream and activate the coagulation cascade, leading to DIC.

**Why the Correct Answer is Right:** Empiric antibiotic therapy for a patient with suspected sepsis and DIC should target the most common gram-negative pathogens causing sepsis. In this case, we should choose an antibiotic that covers Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. These organisms often present as bipolar staining in Gram stain, which is characteristic of their gram-negative rods.

**Why Each Wrong Option is Incorrect:**

A. This antibiotic does not cover the gram-negative rods mentioned above (Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa).
B. Although this antibiotic has activity against some gram-negative organisms, it is not as comprehensive as Option C which covers all three organisms mentioned.
C. This antibiotic covers all three mentioned gram-negative rods and is therefore the most appropriate choice.
D. This antibiotic covers all three mentioned gram-negative rods and has the added advantage of being active against anaerobes and some anaerobic Gram-positive organisms, making it a comprehensive choice.

**Clinical Pearl:** In sepsis patients with DIC, choosing a broad-spectrum antibiotic like Option D is crucial to cover both gram-negative and potentially co-existing anaerobic infections. This increases the chances of successful treatment and reduces the risk of antibiotic resistance.

**Correct Answer:** D. **Doxycycline** is a broad-spectrum antibiotic that covers the three mentioned gram-negative rods (Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa) and is active against anaerobes and some anaerobic Gram-positive organisms. This makes it a suitable choice for treating sepsis patients with DIC and suspected gram-negative infections.